Product Information
SEVELAMER 0.8 GM POWDER PACKET is a generic product labeled by Bionpharma Inc., priced at $0.9196 per EA under NDC 69452012619. Its NADAC has been published 211 times since Sep 21, 2022.
FDA first approved this application on May 17, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Bionpharma Inc.NDC
69452012619
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SEVELAMER CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA209374FDA Approved
5/17/2021
TE Code
AB
On Market Since
9/1/2021
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER 0.8 GM POWDER PACKET has been published 211 times since Sep 21, 2022, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9196 per EA |
|---|---|
| All-time high | $4.0584 (May 10, 2023) |
| All-time low | $0.9196 (Sep 23, 2026) |
| 52-week high | $1.3606 |
| 52-week low | $0.9196 |
| Median price | $1.5133 |
| Average price | $2.0072 |
| Largest weekly change | -33.1% (May 17, 2023) |
| Weeks tracked | 211 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sevelamer Carbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sevelamer Carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEVELAMER 0.8 GM POWDER PACKET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER 0.8 GM POWDER PACKET, manufactured by Bionpharma Inc., is $0.9196 per EA (NDC 69452012619), effective Sep 30, 2026.
How has the price of SEVELAMER 0.8 GM POWDER PACKET changed over time?
Over the history we have for it, the NADAC for SEVELAMER 0.8 GM POWDER PACKET has declined 70.3%. It has been tracked across 211 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for SEVELAMER 0.8 GM POWDER PACKET?
Since Sep 21, 2022, the NADAC for SEVELAMER 0.8 GM POWDER PACKET has ranged from a low of $0.9196 (Sep 23, 2026) to a high of $4.0584 (May 10, 2023), with a median of $1.5133 per EA.
Are there cheaper alternatives to SEVELAMER 0.8 GM POWDER PACKET?
No other NADAC-published product currently shares the active ingredient and strength of SEVELAMER 0.8 GM POWDER PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SEVELAMER 0.8 GM POWDER PACKET?
SEVELAMER 0.8 GM POWDER PACKET (NDC 69452012619) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.